Lever Bio Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $10.5M

  • Investors
  • 6

Lever Bio General Information

Description

Operator of a biotechnology company designed to develop next-generation immuno-oncology therapies. The company's technology leverages metabolic and immune system reprogramming to overcome resistance to existing cancer treatments by enhancing the recruitment, activation, and sustained function of cytotoxic T lymphocytes against solid tumors, enabling healthcare professionals to improve patient outcomes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Via Ettore De Sonnaz 19
  • 10121 Turin
  • Italy
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Via Ettore De Sonnaz 19
  • 10121 Turin
  • Italy

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lever Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 22-Dec-2025 $10.5M Completed Clinical Trials - General
To view Lever Bio’s complete valuation and funding history, request access »

Lever Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lever Bio Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
3LB Seed Capital Holding Company Minority
Claris Ventures Venture Capital Minority
Club degli investitori Angel Group Minority
Exor PE/Buyout Minority
Italian Angels for Growth Angel Group Minority
You’re viewing 5 of 6 investors. Get the full list »

Lever Bio FAQs

  • When was Lever Bio founded?

    Lever Bio was founded in 2024.

  • Where is Lever Bio headquartered?

    Lever Bio is headquartered in Turin, Italy.

  • What is the size of Lever Bio?

    Lever Bio has 6 total employees.

  • What industry is Lever Bio in?

    Lever Bio’s primary industry is Drug Discovery.

  • Is Lever Bio a private or public company?

    Lever Bio is a Private company.

  • What is Lever Bio’s current revenue?

    The current revenue for Lever Bio is .

  • How much funding has Lever Bio raised over time?

    Lever Bio has raised $10.5M.

  • Who are Lever Bio’s investors?

    3LB Seed Capital, Claris Ventures, Club degli investitori, Exor, and Italian Angels for Growth are 5 of 6 investors who have invested in Lever Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process